title: NPY and energy homeostasis: an opportunity for novel anti-obesity therapies.
authors.affiliation: Metabolic Disorders, Merck Research Laboratories, Rahway, NJ 07090, USA. doug_macneil@merck.com
authors.forename: Douglas J
authors.initials: DJ
authors.lastname: MacNeil
authors.forename: Akio
authors.initials: A
authors.lastname: Kanatani
mesh_terms: D000818:Animals; D019440:Anti-Obesity Agents / Q000627:therapeutic use*; D004734:Energy Metabolism / Q000187:drug effects / Q000235:genetics / Q000502:physiology*; D006706:Homeostasis / Q000187:drug effects / Q000235:genetics / Q000502:physiology*; D006801:Humans; D009478:Neuropeptide Y / Q000819:agonists / Q000235:genetics / Q000502:physiology*; D009765:Obesity / Q000188:drug therapy* / Q000378:metabolism*
chemical_list: D019440:Anti-Obesity Agents; D009478:Neuropeptide Y